Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennie Taylor

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Otolaryngologic Clinics of North America|April 9, 2011
Dizziness and vertigo in the adolescentJennie Taylor, Howard P Goodkin
Current Treatment Options in Neurology|February 19, 2013
Anti-angiogenic therapy in high-grade glioma (treatment and toxicity)Jennie Taylor, Elizabeth R Gerstner
Neuro-Oncology Practice|May 11, 2026
Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient communityNaomi Hoffer, Eduardo Rodriguez Almaraz, Lacy Fetting, et al.
Neuro-Oncology Practice|August 9, 2020
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumorsJesus-Eduardo Rodriguez-Almaraz, Susan Chang, Jennifer Clarke, et al.
Journal of Neuro-Oncology|January 6, 2025
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade gliomaKazim H Narsinh, Karishma Kumar, Krystof Bankiewicz, et al.
Neuro-Oncology Advances|October 30, 2023
Quantitative analysis of <i>MGMT</i> promoter methylation in glioblastoma suggests nonlinear prognostic effectDavid Gibson, Akshay Ravi, Eduardo Rodriguez, et al.
Research Square|April 16, 2025
Spatial synaptic connectivity underlies oligodendroglioma evolution and recurrenceDavid Raleigh, Kanish Mirchia, Sena Oten, et al.
Journal of Neuro-Oncology|June 14, 2021
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendrogliomaNancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, et al.
Journal of Neuro-Oncology|May 1, 2020
The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollmentRamin A Morshed, Sheantel J Reihl, Annette M Molinaro, et al.
Neuro-Oncology|July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastomaChristine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Otolaryngologic Clinics of North America|April 9, 2011
Dizziness and vertigo in the adolescentJennie Taylor, Howard P Goodkin
Current Treatment Options in Neurology|February 19, 2013
Anti-angiogenic therapy in high-grade glioma (treatment and toxicity)Jennie Taylor, Elizabeth R Gerstner
Neuro-Oncology Practice|May 11, 2026
Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient communityNaomi Hoffer, Eduardo Rodriguez Almaraz, Lacy Fetting, et al.
Neuro-Oncology Practice|August 9, 2020
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumorsJesus-Eduardo Rodriguez-Almaraz, Susan Chang, Jennifer Clarke, et al.
Journal of Neuro-Oncology|January 6, 2025
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade gliomaKazim H Narsinh, Karishma Kumar, Krystof Bankiewicz, et al.
Neuro-Oncology Advances|October 30, 2023
Quantitative analysis of <i>MGMT</i> promoter methylation in glioblastoma suggests nonlinear prognostic effectDavid Gibson, Akshay Ravi, Eduardo Rodriguez, et al.
Research Square|April 16, 2025
Spatial synaptic connectivity underlies oligodendroglioma evolution and recurrenceDavid Raleigh, Kanish Mirchia, Sena Oten, et al.
Journal of Neuro-Oncology|June 14, 2021
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendrogliomaNancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, et al.
Journal of Neuro-Oncology|May 1, 2020
The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollmentRamin A Morshed, Sheantel J Reihl, Annette M Molinaro, et al.
Neuro-Oncology|July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastomaChristine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.
Pageof 2